You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Vaccines
GC Biopharma secures first Latin American approval for BARYCELA Inj.
Login
Username:

Password:


Related Headlines

Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial

Delonix Bioworks gets IND clearance for DX-104 in China

Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil

European Commission approves GSK's Arexvy for adults aged 18 and over

PhotonPharma adds Dr. William Warren to board

Clover Biopharmaceuticals enrols first participants in Phase 2 trial of respiratory combination vaccine candidates

GSK wins European Commission approval for Shingrix prefilled syringe

Sanofi agrees USD2.2bn acquisition of Dynavax to strengthen adult vaccine portfolio

ECO Animal Health Group secures EU approval for ECOVAXXIN MS

Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic

Anixa Biosciences reveals final data from Phase one clinical trial of investigational breast cancer vaccine at 2025 San Antonio Breast Cancer Symposium

Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio

Yuyu Pharma invests in Dalan Animal Health

Avetra unveils site-centric CRO operating model

Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026